A carregar...
Targeted Opioid Receptor Antagonists in the Treatment of Alcohol Use Disorders
In 1994, the US Food and Drug Administration approved the μ-opioid receptor antagonist naltrexone to treat alcohol dependence. However, treatments requiring daily administration, such as naltrexone, are inconsistently adhered to in substance abusing populations, and constant medication exposure can...
Na minha lista:
| Publicado no: | CNS Drugs |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4600601/ https://ncbi.nlm.nih.gov/pubmed/23881605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-013-0096-4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|